InsidersTradesSigma
Discover the complete record of transactions filed by Jan Lundberg, Director. Officer active across 2 companies, notably AlzeCure Pharma AB. In total, 1 disclosures have been recorded. The latest transaction was disclosed on 24 July 2025 — Purchase. Regulator: FIN-FSA. All data is free.
1 of 1 declaration
Jan Lundberg is a Board Member at AlzeCure Pharma AB. He contributes to overseeing the company’s activities and strategic decision-making. His experience in the pharmaceutical sector is an asset for AlzeCure’s development.